With both preclinical and clinical work, Zor Pharmaceuticals has two formulations being evaluated in pancreatic cancer.

Additional indications are also being explored based on the data generated in global trials.  With positive clinical data and one regulatory approval, Zor Pharmaceuticals looks forward to making a positive impact in the treatment of cancer.